Japan Vaccine Market - Imarc Group

1. Japan Vaccine Market Research Report 2024-2032 Author: Elena Anderson Marketing Manager IMARC Group © 2022 IMARC All Rights Reserved Copyright © IMARC Service Pvt Ltd. All Rights Reserved

2. About IMARC Group Report Description International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description Japan Vaccine Market Outlook 2024-2032: According to the latest report by IMARC Group, titled “Vaccine Market: Japan Industry Trends, Size, Share, Growth, Opportunity, and Forecast 2024-2032,“Japan vaccine market size is projected to exhibit a growth rate (CAGR) of 1.93% during 2024-2032. The increasing awareness of the importance of immunization in preventing infectious diseases and the initiatives by the government authorities to promote vaccination programs are the factors responsible for the growth of the Japan vaccine market. Additionally, the need for vaccines is rising owing to the escalating aging population and the growing occurrence of chronic diseases, which is fueling the market. Besides this, the outbreak of the COVID-19 pandemic has accelerated the demand for vaccines, leading to increased investments in research and development as well as the rapid approval and deployment of COVID-19 vaccines, which is further bolstering the market. The market is also supported by advancements in vaccine technology, such as the development of mRNA vaccines, which offer a new approach to vaccine design and production. Request a Free PDF Sample of the Report: https://www.imarcgroup.com/japan-vaccine-market/requestsample

4. Report Description and Highlights Report Description Japan Vaccine Market Trends: Emerging trends in the Japan vaccine market include the growing emphasis on the utilization of personalized medicine and the introduction of vaccines tailored to individual genetic profiles, offering the potential for effective and targeted immunization. In addition to this, there is also a rising interest in therapeutic vaccines, which are designed to treat existing diseases rather than prevent them, opening new avenues for vaccine applications in cancer and chronic infections, which is creating a positive outlook for the market. Furthermore, the market is witnessing increased collaboration between pharmaceutical companies, research institutions, and government authorities to accelerate vaccine development and ensure a robust supply chain, which is expected to drive the Japan vaccine market over the forecasted period. Explore Full Report with TOC & List of Figures: https://www.imarcgroup.com/japan-vaccine-market

5. Report Description and Highlights Report Description • Key Market Segmentation: • The report has segmented the Japan Vaccine market on the basis of product type, treatment type, technology, route of administration, patient type, indication, distribution channel, and end user. • Product Type Insights: • Multivalent Vaccine • Monovalent Vaccine • Treatment Type Insights: • Preventive Vaccine • Therapeutic Vaccine • Patient Type Insights: • Pediatric • Adult

6. Report Description and Highlights Report Description • Technology Insights: • Conjugate Vaccines • Inactivated and Subunit Vaccines • Live Attenuated Vaccines • Recombinant Vaccines • Toxoid Vaccines • Others • Route of Administration Insights: • Intramuscular and Subcutaneous Administration • Oral Administration • Others

7. Report Description and Highlights Report Description • End User Insights: • Bacterial Diseases • Meningococcal Disease • Pneumococcal Disease • Diphtheria/Tetanus/Pertussis (DPT) • Tuberculosis • Haemophilus Influenzae (Hib) • Typhoid • Others • Viral Diseases • Hepatitis • Influenza • Human Papillomavirus (HPV) • Measles/Mumps/Rubella (MMR) • Rotavirus • Herpes Zoster • Varicella • Japanese Encephalitis

8. Report Description and Highlights Report Description • Rubella • Polio • Rabies • Dengue • Others • Indication Insights: • Kanto Region • Kinki Region • Central/ Chubu Region • Kyushu-Okinawa Region • Tohoku Region • Chugoku Region • Hokkaido Region • Shikoku Region • Ask An Analyst for Customization : https://www.imarcgroup.com/request?type=report&id=17199&flag=E

9. Key Questions Answered in the Report Report Description • How has the Japan Vaccine market performed so far and how will it perform in the coming years? • What has been the impact of COVID-19 on the Japan Vaccine market? • What is the breakup of the Japan Vaccine market on the basis of type? • What is the breakup of the Japan Vaccine market on the basis of product type? • What is the breakup of the Japan Vaccine market on the basis of application? • What are the various stages in the value chain of the Japan Vaccine market? • What are the key driving factors and challenges in the Japan Vaccine? • What is the structure of the Japan Vaccine market and who are the key players? • What is the degree of competition in the Japan Vaccine market?

10. Table of Contents Report Description 1 Preface 2 Scope and Methodology 3 Executive Summary 4 Japan Vaccine Market - Introduction 5 Japan Vaccine Market Landscape 6 Japan Vaccine Market - Breakup by Product Type 7 Japan Vaccine Market - Breakup by Treatment Type 8 Japan Vaccine Market - Breakup by Technology 9 Japan Vaccine Market - Breakup by Route of Administration 10 Japan Vaccine Market - Breakup by Patient Type

11. Table of Contents Report Description 11 Japan Vaccine Market - Breakup by Indication 12 Japan Vaccine Market - Breakup by Distribution Channel 13 Japan Vaccine Market - Breakup by End User 14 Japan Vaccine Market – Breakup by Region 18 Appendix Click Here to Visit the Complete Table of Content With List of Figures and Tables: https://www.imarcgroup.com/japan-vaccine-market/toc

12. Partial List of Clients • We are the trusted business partners to the world's leading corporates, governments, and institutions A partial List of our Clients

13. Partial List of Clients • We are the trusted business partners to the world's leading corporates, governments, and institutions A partial List of our Clients

14. Report Description and Highlights Report Description © 2022 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Japan Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

15. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: • TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com